[Today's focus]

China Traditional Chinese Medicine (00570.HK) was privatized by Sinopharm Group Gongyu at a premium of about 34.11% to resume trading tomorrow

China Traditional Chinese Medicine (00570.HK) announced that on February 9, 2024, the offender Sinopharm Group Gongyu Co., Ltd. requested the board of directors to submit a proposal to the planned shareholders to privatize the company. If approved, it would result in the cancellation of the stock's listing status on the Hong Kong Stock Exchange.

The Board has reviewed the recommendations and agreed to present them to plan shareholders. The cancellation price of HK$4.6 per plan share cancelled in cash according to the plan is about 34.11% higher than the closing price of HK$3.43 per share reported on the Hong Kong Stock Exchange on the last trading day.

The offeror is an exempted company incorporated under the laws of the Cayman Islands. As of the date of this Joint Announcement, the Offeror owned 10,000 shares of issued common stock, of which the controlling shareholder, Investor A, Investor B, Investor C, Investor D, and Investor E each held 5,511, 737, 1,184, 1,138, 1,132 and 298 fully paid offerer shares, accounting for approximately 55.11%, 7.37%, 11.84%, 11.84%, 11.38%, 11.32% and 2.98% of the Offeror's issued share capital, respectively. The Offeror is formed to implement the proposal.

For planned shareholders other than controlling shareholders, this is an attractive opportunity to cash out the investment at a premium. For the company: The company currently has limited functions as a listed financing platform; suggestions are conducive to streamlining the company's governance, corporate and equity structure, and improving management efficiency. For offenders, controlling shareholders and investor groups: this is an opportunity to establish a strategic partnership.

After the proposal is successfully implemented, the offeror plans to review the company's business operations and may seek and explore business opportunities to develop the Group's existing business, depending on the Group's ability to obtain the required capital and current market conditions.

Furthermore, the company has applied to the Hong Kong Stock Exchange to resume share trading from 9:00 a.m. on February 22, 2024.

[Financial results]

Huafa Property Services (00982.HK) Yingxi: Profit attributable to company owners is expected to increase by no less than 20% year-on-year

Haosun Technology (02440.HK) expects annual revenue growth of 34% to 38%

Jinyue Holdings (00070.HK) Profit Alert: Expected to lose about HK$18 million in mid-2023

Loss attributable to shareholders of Yingda Real Estate (00432.HK) HK$466 million for the year

Honghua Group (00196.HK) expects annual shareholder losses to drop sharply

Asia Energy Logistics (00351.HK) expects net profit of around HK$12 million in 2023

Hong Kong Express Holdings (00032.HK) expects a profit of about HK$450 million in 2023 and a loss of HK$445.3 million last year

China Joint Resources (00254.HK) Profit Alert: Expected mid-term loss of HK$20 million to HK$30 million

[Operational data]

China People's Insurance Group (01339.HK)'s original premium revenue in January reached 106.030 billion yuan, a year-on-year increase of 5.46% year-on-year

China Financial Insurance (02328.HK): Premium income reached 62,828 billion yuan in January, up 2.7% year-on-year

Hejing Taifu Group (01813.HK): January pre-sale amount was 830 million yuan

Rongxin China (03301.HK)'s total contract sales in January were about 448 million yuan

[Acquisition and sale]

Jinhui Group (00137.HK) subsidiary plans to acquire a ship for HK$240 million

Tang Yiduan, the single largest shareholder of China Tianhua Chemical (00362.HK), sold a total of 132 million shares of the company to Zhang Hong

Weicheng International (01002.HK) plans to acquire approximately 43.29% of VS Industry Vietnam Joint Stock's share capital for HK$69 million

[Issuance of additional shares]

Green Economy (01315.HK) plans to conduct a net share offering of up to HK$34.5 million under the “2 to 1” share offering

Lingbao Gold (03330.HK) plans to sell 32.54 million shares at a discount of about 19.76% to raise HK$42 million

[Repurchase Cancellation]

Jiangxi Copper Co., Ltd. (00358.HK) plans to repurchase 150 million yuan to 300 million yuan of A shares

AIA (01299.HK) spent HK$71.94 million to buy back 1,112,200 shares on February 21

Yum China (09987.HK) spent HK$3.088 million to buy back 99,400 shares on February 20

Swire Group A (00019.HK) spent HK$14.26 million to repurchase 223,000 shares on February 21

COSCO Marine Holdings (01919.HK) spent HK$11.5,126 million to buy back 1.35 million shares on February 21

Fangda Holdings (01521.HK) spent HK$6.947 million to repurchase 3.8 million shares on February 21

Wanwuyun (02602.HK) spent HK$3.726 million to repurchase 200,000 shares on February 21

MineGene (06667.HK) spent HK$2.45 million to buy back 231,000 shares on February 21

Beautiful Garden Healthcare (02373.HK) cancelled 610,000 shares on February 21